|
INPP4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.2882999999595E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.49699999996145E-06 |
| Normal-vs-Stage2 |
7.724100E-03 |
| Normal-vs-Stage3 |
1.106490E-02 |
| Normal-vs-Stage4 |
7.724400E-02 |
| Stage1-vs-Stage2 |
6.998000E-01 |
| Stage1-vs-Stage3 |
9.711600E-02 |
| Stage1-vs-Stage4 |
2.320400E-01 |
| Stage2-vs-Stage3 |
2.016800E-01 |
| Stage2-vs-Stage4 |
2.539600E-01 |
| Stage3-vs-Stage4 |
9.950800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.52719999999751E-05 |
| Normal-vs-AfricanAmerican |
2.375800E-03 |
| Normal-vs-Asian |
4.3923999999973E-05 |
| Caucasian-vs-AfricanAmerican |
2.960400E-01 |
| Caucasian-vs-Asian |
1.164550E-01 |
| AfricanAmerican-vs-Asian |
2.974400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.036970E-04 |
| Normal-vs-Female |
2.08119999999257E-05 |
| Male-vs-Female |
3.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.205700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.49490000051134E-07 |
| Normal-vs-Age(61-80Yrs) |
3.156400E-03 |
| Normal-vs-Age(81-100Yrs) |
5.678800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.490200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.197400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.188000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.399900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.669500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.190000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.604210E-04 |
| Normal-vs-Grade 2 |
4.81829999998684E-06 |
| Normal-vs-Grade 3 |
1.563870E-03 |
| Normal-vs-Grade 4 |
3.944000E-02 |
| Grade 1-vs-Grade 2 |
1.349000E-01 |
| Grade 1-vs-Grade 3 |
2.190100E-02 |
| Grade 1-vs-Grade 4 |
2.748300E-02 |
| Grade 2-vs-Grade 3 |
2.303000E-01 |
| Grade 2-vs-Grade 4 |
2.390200E-01 |
| Grade 3-vs-Grade 4 |
7.678000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.237700E-04 |
| Normal-vs-ccB subtype |
3.24649999994264E-07 |
| ccA subtype-vs-ccB subtype |
2.176400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.73359999999989E-05 |
| Normal-vs-N1 |
2.129600E-01 |
| N0-vs-N1 |
6.650600E-01 |
|
|
